arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

MetaVia Inc.

MTVA
$1.49 ▲ +0.02 (+1.36%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
46 Visible periods
20 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

MetaVia Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $7.2M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -44.4%
FCF / Share $-0.88
Trailing P/E
Price / Book 0.9x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

46-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-3.82M
↓ -4.1%
FCF / Share Free cash flow per share
$-0.88
↑ +83.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
1
Cash Quality
73

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 46 quarters